Cas:43168-51-0 4-Epi Minocycline manufacturer & supplier

Chemical Name:4-Epi Minocycline

CAS.NO:43168-51-0

Synonyms:7-Dimethylamino-4-nitro-benzofuroxan;(4R,4aS,5aR,12aS)-4,7-Bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-2-tetracenecarboxamide;4-Epi Minocycline;minocycline;7-Dimethylamino-6-demethyl-6-deoxytetracyclin,Minocyclin;4-BENZOFURAZANAMINE,N,N-DIMETHYL-7-NITRO-,1-OXIDE;2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4R,4aS,5aR,12aS)-

Molecular Formula:C₂₃H₂₇N₃O₇

Molecular Weight:457.476

HS Code:

Physical and Chemical Properties:

Melting point:>196ºC (dec)

Boiling point:803.3±65.0 °C at 760 mmHg

Density:1.6±0.1 g/cm3

Index of Refraction:1.718

PSA:164.63000

Exact Mass:457.184906

LogP:-0.65

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 7-Dimethylamino-4-nitro-benzofuroxan chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4R,4aS,5aR,12aS)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4R,4aS,5aR,12aS)- Use and application,minocycline technical grade,usp/ep/jp grade.

Related News: This also includes experience for drug delivery systems, efficient teams, facilities, and production capabilities. (E)-But-2-enoic acid 2,6-dinitro-4-(1-propyl-butyl)-phenyl ester manufacturers The group, after examining Soliris’ late-stage trial data, determined they’re highly certain it produces a small benefit to patients who are positive for anti-AChR antibodies, while there’s a “moderate certainty of a small or substantial net health benefit.” Ethyl (E)-3-(4-[2-(6-carbamoyl-1-methyl-1H-3-indolyl)-2-(1,3-benzodioxol-5-yl)acetyl]sulfamoylphenyl)-2-propenoate suppliers These studies have revealed a high rate of success among many of its compounds (see Mindset’s news release of April 29, 2021), giving Mindset an exceptional pool of new drug candidates from which it will continue to identify additional suitable compounds. 6-(4-azido-1-((triethylsilyl)oxy)butyl)-5-hydroxy-2,3-dimethyl-5,6-dihydrocyclopenta[b]pyrrol-4(1H)-one vendor & factory.